Acupuncture for Inflammatory Pain and Central Sensitization - A Pilot Study

Sponsor
University of Vermont (Other)
Overall Status
Completed
CT.gov ID
NCT01945190
Collaborator
Stanford University (Other)
15
1
2
30
15.2

Study Details

Study Description

Brief Summary

Acupuncture is used extensively by patients worldwide for a variety of illnesses. While research is beginning to show effectiveness in clinical pain, the mechanisms underlying how these effects are evoked are poorly understood. Experimental models in healthy human volunteers can more closely control the variables of acupuncture needling and begin to separate out the relative contribution of specific components of needling and needle stimulation. By examining acupuncture's effects on experimental inflammatory models with well-characterized physiologic mechanisms, hypotheses can begin to be generated regarding how acupuncture produces its clinical effects. We propose to establish a model which could be used as a template to examine the individual components contributing to acupuncture's clinical effects on inflammation and pain. We hypothesize that acupuncture will have analgesic and anti-inflammatory effects on a ultraviolet B induced cutaneous lesion as well as a model of heat pain testing which activates central sensitization.

Twenty healthy human volunteers will participate in a crossover study with active acupuncture and sham acupuncture interventions. They will be tested for their minimal erythemal dose (MED) to ultraviolet B exposure. An experimental lesion at 3x MED will be administered on the lower leg. Background information will be collected which could affect individuals' sensitivity to pain such as anxiety and depression, as well as their expectations regarding acupuncture treatment.

The following day they will return for the first experimental day. A measurement with Laser Doppler will quantify the inflammation in the ultraviolet B lesion. Heat pain testing will be performed using a computer controlled thermode both on and off the ultraviolet B lesion. On-lesion testing will be for heat pain threshold. Off-lesion testing will examine temporal summation of heat pain.

Next, a licensed acupuncturist will perform either true electroacupuncture or sham electroacupuncture in the region adjacent to the ultraviolet B lesion. Participants are blinded to the intervention, as is the examiner collecting data. Afterwards, Laser Doppler and heat pain testing will be repeated. The difference between pre-acupuncture and post-acupuncture measurements will represent the acupuncture -induced analgesic and anti-inflammatory effects.

Participants will return for another ultraviolet B exposure adjacent to the first, and will receive whichever sham or true acupuncture intervention was not performed on the first study day.

Condition or Disease Intervention/Treatment Phase
  • Device: Electroacupuncture
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Acupuncture for Inflammatory Pain and Central Sensitization - A Pilot Study
Study Start Date :
Sep 1, 2013
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Oct 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: True before sham electroacupuncture

Crossover design, individuals randomized to receive either true or sham acupuncture in first study day, and on the second study day whichever intervention was not administered on the first study day.

Device: Electroacupuncture

Experimental: Sham before true electroacupuncture

Crossover design, individuals randomized to receive either true or sham acupuncture in first study day, and on the second study day whichever intervention was not administered on the first study day.

Device: Electroacupuncture

Outcome Measures

Primary Outcome Measures

  1. Erythema as measured by Laser Doppler [within one day]

    Participants are studied in two separate sessions each contained within one day, and each lasting approximately 3 hours. Participants' pre-acupuncture treatment data are compared to post-acupuncture data to assess effect of acupuncture

  2. Heat pain threshold (deg C) [within one day]

    Participants are studied in two separate sessions each contained within one day, and each lasting approximately 3 hours. Participants' pre-acupuncture treatment data are compared to post-acupuncture data to assess effect of acupuncture

  3. Analgesia to temporal summation of heat pain [within one day]

    Temporal summation of pain is an increased magnitude of response to repetitive stimulus administration. Participants are studied in two separate sessions each contained within one day, and each lasting approximately 3 hours. Participants' pre-acupuncture treatment data are compared to post-acupuncture data to assess effect of acupuncture

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults aged 18-70
Exclusion Criteria:
  • Clinically relevant systemic diseases such as psychiatric, neurological, and dermatological conditions interfering with the collection and interpretation of study data

  • Chronic or recent use of medication potentially interfering with pain processing (except oral contraceptives)

  • Intake of analgesics within the two days prior to study

  • Participation in other research studies within the previous 30 days

  • Having previously received acupuncture treatments

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University Stanford California United States 94304

Sponsors and Collaborators

  • University of Vermont
  • Stanford University

Investigators

  • Principal Investigator: Nicholas Phillips, BS, BA, MTOM, University of Vermont
  • Study Director: Helene Langevin, MD, University of Vermont

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nicholas Phillips, MD Candidate, University of Vermont
ClinicalTrials.gov Identifier:
NCT01945190
Other Study ID Numbers:
  • 14-079
  • 28064
First Posted:
Sep 18, 2013
Last Update Posted:
Oct 17, 2013
Last Verified:
Oct 1, 2013
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 17, 2013